Macrophage migration inhibitory factor may contribute to hypertrophy of lumbar ligamentum flavum in type 2 diabetes mellitus

被引：0

作者：

Lu QiLin ^{[1
,2
,3
,4
,5
,6
]}

Wang XiaoZhen ^{[1
,2
,3
,4
,5
,6
]}

Xie Wei ^{[1
,2
,3
,4
,5
,6
]}

Chen XiongWei ^{[1
,2
,3
,4
,5
,6
]}

Zhu YiLiang ^{[1
,2
,3
,4
,5
,6
]}

Li XuGui

机构：

[1] ChinaDepartmentofOrthopedics

[2] DepartmentofOrthopedics

[3] Hubei430065

[4] Hubei672OrthopaedicsHospitalofIntegratedChinese&WesternMedicine

[5] HubeiUniversityofChineseMedicine

[6] Wuhan

来源：

中华医学杂志英文版 | 2020年 / 133卷 / 05期

关键词：

D O I：

暂无

中图分类号：

+ [];

学科分类号：

摘要：

<正>To the Editor: Lumbar spinal canal stenosis (LSCS) is a common disease among older individuals. Hypertrophic lumbar ligamentum flavum (LLF) plays a vital role in the pathogenesis of LSCS. The physiolo

引用

页码：623 / 624-625

共 50 条

[1] Macrophage migration inhibitory factor may contribute to hypertrophy of lumbar ligamentum flavum in type 2 diabetes mellitus
Lu, Qi-Lin
Wang, Xiao-Zhen
Xie, Wei
Chen, Xiong-Wei
Zhu, Yi-Liang
Li, Xu-Gui
CHINESE MEDICAL JOURNAL, 2020, 133 (05) : 623 - 625
[2] Macrophage migration inhibitory factor takes part in the lumbar ligamentum flavum hypertrophy
Lu, Qi-Lin
Zheng, Zi-Xuan
Ye, Yu-Hui
Lu, Jiang-Yun
Zhong, Yu-Qi
Sun, Chao
Xiong, Cheng-Jie
Yang, Gong-Xu
Xu, Feng
MOLECULAR MEDICINE REPORTS, 2022, 26 (03)
[3] Macrophage polarization and macrophage-related factor expression in hypertrophy of the ligamentum flavum
Jiang, Cheng
Wang, Wei
Chen, Yong-Long
Chen, Jiong-Hui
Zhang, Zhen-Wu
Li, Jun
Yang, Zhi-Chao
Li, Xiao-Chuan
EUROPEAN SPINE JOURNAL, 2024, 33 (12) : 4476 - 4487
[4] Transforming growth factor β/Smad pathway participates in lumbar ligamentum flavum hypertrophy
Chen, Jianwei
Li, Zhanchun
Chen, Haihong
Ji, Hao
Deng, Chao
Liu, Zude
Zhong, Guibin
Shen, Hongxing
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (05): : 5197 - 5204
[5] Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis
Heidemarie Becker
Peter Willeke
Heiko Schotte
Wolfram Domschke
Markus Gaubitz
Clinical Rheumatology, 2008, 27 : 1307 - 1311
[6] Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis
Becker, Heidemarie
Willeke, Peter
Schotte, Heiko
Domschke, Wolfram
Gaubitz, Markus
CLINICAL RHEUMATOLOGY, 2008, 27 (10) : 1307 - 1311
[7] Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus
Martin, R. J. L.
Savage, D. A.
Carson, D. J.
McKnight, A. J.
Maxwell, A. P.
Patterson, C. C.
DIABETIC MEDICINE, 2010, 27 (02) : 143 - 149
[8] Macrophage Infiltration Is a Causative Factor for Ligamentum Flavum Hypertrophy through the Activation of Collagen Production in Fibroblasts
Saito, Takeyuki
Hara, Masamitsu
Kumamaru, Hiromi
Kobayakawa, Kazu
Yokota, Kazuya
Kijima, Ken
Yoshizaki, Shingo
Harimaya, Katsumi
Matsumoto, Yoshihiro
Kawaguchi, Kenichi
Hayashida, Mitsumasa
Inagaki, Yutaka
Shiba, Keiichiro
Nakashima, Yasuharu
Okada, Seiji
AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (12): : 2831 - 2840
[9] Macrophage migration inhibitory factor may contribute to the occurrence of multiple primary lung adenocarcinomas
Liu, Wei
Yang, Hao-Shuai
Zhi, Fei-Hang
Feng, Yan-Fen
Luo, Hong-He
Zhu, Ying
Lei, Yi-Yan
CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (10):
[10] Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus
Stosic-Grujicic, Stanislava
Stojanovic, Ivana
Maksimovic-Ivanic, Danijela
Momcilovic, Miljana
Popadic, Dusan
Harhaji, Ljubica
Miljkovic, Djordje
Metz, Christine
Mangano, Katia
Papaccio, Gianpacilo
Al-Abed, Yousef
Nicolett, Ferdinando
JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 215 (03) : 665 - 675

← 1 2 3 4 5 →